After an acute coronary syndrome: levosimendan or dobutamine? this is our impression
Sign Up to like & getrecommendations! Published in 2023 at "European Heart Journal: Acute Cardiovascular Care"
DOI: 10.1093/ehjacc/zuad036.110
Abstract: Type of funding sources: None. Inotropic support is frequently needed after acute coronary syndromes(ACS) at coronary care units(CCU). Despite it has being long time since approval of levosimendan(LV) as inotropic support to cardiogenic shock, dobutamine(DB)… read more here.
Keywords: levosimendan dobutamine; coronary syndrome; levosimendan; acute coronary ... See more keywords